Feasibility of DNA Methylation Age as a Biomarker of Symptoms and Resilience among Cancer Survivors with Multiple Chronic Conditions

This study aims to examine the feasibility of DNA methylation age as a biomarker for symptoms and resilience in cancer survivors with multiple chronic conditions (MCCs). We included ten participants from our parent study, an ongoing randomized control trial study. Participants’ symptoms and resilien...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukkahatai, Nada, Park, Jongmin, Jia, Hejingzi Monica, Martin, Daniel, Li, Junxin, Sheng, Jennifer Yeong-Shin, Gill, Jessica, Saligan, Leorey N., Stearns, Vered, Carducci, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669866/
https://www.ncbi.nlm.nih.gov/pubmed/38002076
http://dx.doi.org/10.3390/biomedicines11113076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669866/
https://www.ncbi.nlm.nih.gov/pubmed/38002076
http://dx.doi.org/10.3390/biomedicines11113076

Ejemplares similares